Biotechnology

Filter

Current filters:

None

Popular Filters

1890 to 1914 of 2323 results

Onyx Pharma links with Texas MD Anderson Cancer Center on research

05-06-2012

US biotech firm Onyx Pharmaceuticals (Nasdaq: ONXX) and The University of Texas MD Anderson Cancer Center…

BiotechnologycarfilzomibOncologyOnyx PharmaceuticalsoprozomibResearch

Rindopepimut likely to be Rxed by 36% of surveyed US oncologists for GMB patients

05-06-2012

US oncologists surveyed by advisory firm Decision Resources indicate that they would prescribe the emerging…

BiotechnologyCelldex TherapeuticsMarkets & MarketingNorth AmericaOncologyPharmaceuticalrindopepimut

NicOx drops its option to take full ownership of Altacor

04-06-2012

French biotechnology firm NicOx (NYSE Euronext Paris: COX) said last Friday that its board of directors…

AltacorBiotechnologyMergers & AcquisitionsNicOxOphthalmics

EMA boosts EU transparency with on-line publication of suspected side effect reports

31-05-2012

The European Medicines Agency yesterday began publishing suspected side effect reports for medicines…

BiotechnologyEuropePharmaceuticalRegulation

Alnylam's RSV drug candidate misses primary endpoint in Ph IIb

31-05-2012

Leading USA-based RNAi therapeutics firm Alnylam Pharmaceuticals (Nasdaq: ALNY) yesterday announced disappointing…

Alnylam PharmaceuticalsBiotechnologyResearchRespiratory and Pulmonary

BioAlliance's Sitavig NDA "receivable" by US FDA

30-05-2012

French biotech firm BioAlliance Pharma (Euronext Paris: BIO) has announced the receivability of its Sitavig…

Anti-viralsBioAlliance PharmaBiotechnologyNorth AmericaRegulationSitavigSitavir

Expanded Access Program for enzalutamide agreed with US FDA

30-05-2012

The US Food and Drug Administration agreed that Medivation (Nasdaq: MDVN) and Japanese drug major Astellas…

Astellas PharmaBiotechnologyenzalutamideMDV3100MedivationNorth AmericaOncologyPharmaceuticalRegulation

US legislation could block public access to drug safety information, claim consumer groups

30-05-2012

A provision in the Food and Drug Administration Reform Act that would block public access to potentially…

BiotechnologyNorth AmericaPharmaceuticalPoliticsRegulation

Genentech links up with Ensemble Thera for macrocyclic drug candidates discovery

30-05-2012

Swiss drug major Roche's (ROG: SIX) subsidiary Genentech has initiated a drug discovery collaboration…

BiotechnologyEnsemble TherapeuticsGenentechLicensingResearchRoche

Rainbow BioSci seeks to develop treatment for traumatic brain injury

29-05-2012

USA-based Rainbow BioSciences, the biotech subsidiary of Rainbow Coral Corp (OTCBB: RBCC) revealed yesterday…

Amarantus BioSciencesBiotechnologyLicensingNeurologicalRainbow Biosciences

UK health and life sciences group agrees new clinical trials transparency principles

28-05-2012

The Ethical Standards in Health and Life Sciences Group (ESHLSG), a partnership including the Association…

BiotechnologyEuropePharmaceuticalRegulationResearch

EMA orphan drug committee makes 16 recommendations at May meeting

28-05-2012

The European Medicines Agency's Committee for Orphan Medicinal Products (COMP) adopted a total of 16…

Alexion PharmaceuticalsBiotechnologyeculizumabEuropePharmaceuticalRare diseasesRegulation

US Senate passing of FDA Safety and Innovation Act lauded by biotech and pharma industry

28-05-2012

The US Senate approved the Food and Drug Administration Safety and Innovation Act (FDASIA), which includes…

BiotechnologyFinancialLegalNorth AmericaPharmaceuticalPoliticsRegulation

EMA confirms Roche's MabThera made at Vacaville site poses no health risk

28-05-2012

Following a quality review of the genetically engineered monoclonal antibody MabThera, the European Medicines…

Anti-Arthritics/RheumaticsBiotechnologyMabTheraOncologyPharmaceuticalRegulationRoche

Positive results for Regeneron and Sanofi's SAR236553/REGN727

27-05-2012

USA-based Regeneron (Nasdaq: REGN) and French drug major Sanofi (Euronext: SAN) presented results of…

BiotechnologyCardio-vascularPharmaceuticalRegeneronResearchSanofi

Israel's Thrombotech and D-Pharm to merge

25-05-2012

intellectual property developed and owned by Hadassah University Hospital, Israel's foremost medical…

BiotechnologyD-PharmHadasit Bio-HoldingsMergers & AcquisitionsThrombotech

Australia's TGA launches consultation on better medicines labeling

24-05-2012

Australia's medicine's regulator, the Therapeutic Goods Administration, has this week released a consultation…

Asia-PacificBiotechnologyGenericsPharmaceuticalRegulation

1890 to 1914 of 2323 results

Back to top